nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—hindbrain—Parkinson's disease	0.0799	0.174	CbGeAlD
Tyloxapol—LPL—Composition of Lipid Particles—APOE—Parkinson's disease	0.0503	0.0931	CbGpPWpGaD
Tyloxapol—LPL—embryo—Parkinson's disease	0.05	0.109	CbGeAlD
Tyloxapol—LPL—brainstem—Parkinson's disease	0.0458	0.0995	CbGeAlD
Tyloxapol—LPL—forebrain—Parkinson's disease	0.0442	0.096	CbGeAlD
Tyloxapol—LPL—cardiovascular system—Parkinson's disease	0.0374	0.0812	CbGeAlD
Tyloxapol—LPL—medulla oblongata—Parkinson's disease	0.0319	0.0694	CbGeAlD
Tyloxapol—LPL—Chylomicron-mediated lipid transport—APOE—Parkinson's disease	0.0302	0.056	CbGpPWpGaD
Tyloxapol—LPL—midbrain—Parkinson's disease	0.0292	0.0634	CbGeAlD
Tyloxapol—LPL—spinal cord—Parkinson's disease	0.0285	0.0619	CbGeAlD
Tyloxapol—LPL—Alzheimers Disease—SNCA—Parkinson's disease	0.027	0.05	CbGpPWpGaD
Tyloxapol—LPL—head—Parkinson's disease	0.0253	0.055	CbGeAlD
Tyloxapol—LPL—nervous system—Parkinson's disease	0.024	0.0521	CbGeAlD
Tyloxapol—LPL—central nervous system—Parkinson's disease	0.0231	0.0502	CbGeAlD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CYP2E1—Parkinson's disease	0.0231	0.0427	CbGpPWpGaD
Tyloxapol—LPL—cerebellum—Parkinson's disease	0.0226	0.0491	CbGeAlD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.0216	0.04	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—APOE—Parkinson's disease	0.0197	0.0365	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—APOE—Parkinson's disease	0.0192	0.0356	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MAPT—Parkinson's disease	0.0189	0.0351	CbGpPWpGaD
Tyloxapol—LPL—brain—Parkinson's disease	0.0183	0.0399	CbGeAlD
Tyloxapol—LPL—Retinoid metabolism and transport—APOE—Parkinson's disease	0.015	0.0277	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—GRIN2B—Parkinson's disease	0.014	0.026	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CYCS—Parkinson's disease	0.0133	0.0246	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—APOE—Parkinson's disease	0.0128	0.0236	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NRTN—Parkinson's disease	0.0121	0.0224	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—APOE—Parkinson's disease	0.00885	0.0164	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—INS—Parkinson's disease	0.00842	0.0156	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOE—Parkinson's disease	0.00763	0.0141	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—DLG1—Parkinson's disease	0.00755	0.014	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00696	0.0129	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00631	0.0117	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—GDNF—Parkinson's disease	0.00591	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—IL1B—Parkinson's disease	0.00564	0.0104	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP3—Parkinson's disease	0.00563	0.0104	CbGpPWpGaD
Tyloxapol—LPL—Disease—VPS35—Parkinson's disease	0.00526	0.00973	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—INS—Parkinson's disease	0.00507	0.0094	CbGpPWpGaD
Tyloxapol—LPL—Disease—MCCC1—Parkinson's disease	0.00489	0.00905	CbGpPWpGaD
Tyloxapol—LPL—Disease—OMD—Parkinson's disease	0.00459	0.00851	CbGpPWpGaD
Tyloxapol—LPL—Disease—TALDO1—Parkinson's disease	0.00459	0.00851	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00435	0.00805	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—Parkinson's disease	0.00418	0.00774	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—Parkinson's disease	0.00409	0.00758	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MCCC1—Parkinson's disease	0.00409	0.00758	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ND3—Parkinson's disease	0.00409	0.00758	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—OMD—Parkinson's disease	0.00385	0.00712	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TALDO1—Parkinson's disease	0.00385	0.00712	CbGpPWpGaD
Tyloxapol—LPL—Disease—TAF1—Parkinson's disease	0.0037	0.00686	CbGpPWpGaD
Tyloxapol—LPL—Disease—FBP1—Parkinson's disease	0.0037	0.00686	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VPS35—Parkinson's disease	0.00368	0.00682	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NDUFB11—Parkinson's disease	0.00365	0.00675	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HSPA8—Parkinson's disease	0.00353	0.00654	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCH1—Parkinson's disease	0.00348	0.00644	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—DLG4—Parkinson's disease	0.00331	0.00613	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—GRIN2B—Parkinson's disease	0.00324	0.006	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00314	0.00581	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—DBH—Parkinson's disease	0.0031	0.00574	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GBA—Parkinson's disease	0.0031	0.00574	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FBP1—Parkinson's disease	0.0031	0.00574	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DGKQ—Parkinson's disease	0.00305	0.00565	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GPR37—Parkinson's disease	0.00305	0.00565	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPL6—Parkinson's disease	0.00296	0.00548	CbGpPWpGaD
Tyloxapol—LPL—Disease—SNCA—Parkinson's disease	0.00296	0.00548	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00279	0.00517	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—Parkinson's disease	0.00275	0.00509	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ABL1—Parkinson's disease	0.00264	0.00489	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RIT2—Parkinson's disease	0.00244	0.00451	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRK5—Parkinson's disease	0.00231	0.00428	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—DDC—Parkinson's disease	0.00228	0.00421	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPL14—Parkinson's disease	0.00224	0.00415	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPL23A—Parkinson's disease	0.00224	0.00415	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—Parkinson's disease	0.00222	0.00411	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA4—Parkinson's disease	0.00215	0.00398	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00212	0.00393	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF20—Parkinson's disease	0.00209	0.00387	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPS8—Parkinson's disease	0.00209	0.00387	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRM4—Parkinson's disease	0.00207	0.00384	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PENK—Parkinson's disease	0.00197	0.00364	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAG—Parkinson's disease	0.00197	0.00364	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLA2G6—Parkinson's disease	0.00194	0.00358	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MAOB—Parkinson's disease	0.00192	0.00355	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00182	0.00338	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDYN—Parkinson's disease	0.0018	0.00333	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—INS—Parkinson's disease	0.00174	0.00323	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GFAP—Parkinson's disease	0.00169	0.00313	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRM5—Parkinson's disease	0.00167	0.00309	CbGpPWpGaD
Tyloxapol—LPL—Disease—ADRBK1—Parkinson's disease	0.00154	0.00285	CbGpPWpGaD
Tyloxapol—LPL—Disease—HSPA1A—Parkinson's disease	0.00153	0.00283	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF20—Parkinson's disease	0.00147	0.00271	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2D6—Parkinson's disease	0.00142	0.00264	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADORA2A—Parkinson's disease	0.00142	0.00263	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CTGF—Parkinson's disease	0.0014	0.00259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INSR—Parkinson's disease	0.00131	0.00243	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2E1—Parkinson's disease	0.0013	0.00241	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NQO1—Parkinson's disease	0.00129	0.00238	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TH—Parkinson's disease	0.00127	0.00235	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGB—Parkinson's disease	0.00124	0.00229	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR1A—Parkinson's disease	0.00123	0.00228	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYCS—Parkinson's disease	0.00122	0.00226	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TAC1—Parkinson's disease	0.00121	0.00225	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD1—Parkinson's disease	0.00119	0.0022	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD3—Parkinson's disease	0.00115	0.00214	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COMT—Parkinson's disease	0.00108	0.002	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRBK1—Parkinson's disease	0.00108	0.00199	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—Parkinson's disease	0.00107	0.00199	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MAOA—Parkinson's disease	0.00107	0.00198	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—Parkinson's disease	0.00106	0.00196	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR7—Parkinson's disease	0.00104	0.00193	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD2—Parkinson's disease	0.00104	0.00193	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—Parkinson's disease	0.00104	0.00193	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—Parkinson's disease	0.00102	0.00188	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—Parkinson's disease	0.000987	0.00183	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOE—Parkinson's disease	0.00097	0.0018	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—Parkinson's disease	0.000945	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—Parkinson's disease	0.000944	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF2—Parkinson's disease	0.000874	0.00162	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—Parkinson's disease	0.000872	0.00162	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1R—Parkinson's disease	0.000845	0.00156	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDN1—Parkinson's disease	0.000835	0.00155	CbGpPWpGaD
Tyloxapol—LPL—Disease—INS—Parkinson's disease	0.000828	0.00153	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOE—Parkinson's disease	0.000812	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGF—Parkinson's disease	0.000767	0.00142	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—Parkinson's disease	0.000762	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR2A—Parkinson's disease	0.00073	0.00135	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—INS—Parkinson's disease	0.000694	0.00128	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOE—Parkinson's disease	0.000679	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INS—Parkinson's disease	0.00058	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—Parkinson's disease	0.000432	0.0008	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK8—Parkinson's disease	0.000397	0.000735	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—Parkinson's disease	0.000362	0.00067	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—Parkinson's disease	0.000253	0.000469	CbGpPWpGaD
